Cytokinetics (CYTK) Shares Outstanding (2016 - 2025)
Historic Shares Outstanding for Cytokinetics (CYTK) over the last 16 years, with Q3 2024 value amounting to $117.9 million.
- Cytokinetics' Shares Outstanding rose 2247.93% to $117.9 million in Q3 2024 from the same period last year, while for Sep 2024 it was $117.9 million, marking a year-over-year increase of 2247.93%. This contributed to the annual value of $101.6 million for FY2023, which is 717.46% up from last year.
- Latest data reveals that Cytokinetics reported Shares Outstanding of $117.9 million as of Q3 2024, which was up 2247.93% from $117.5 million recorded in Q2 2024.
- Cytokinetics' Shares Outstanding's 5-year high stood at $117.9 million during Q3 2024, with a 5-year trough of $59.5 million in Q1 2020.
- Moreover, its 5-year median value for Shares Outstanding was $85.9 million (2022), whereas its average is $87.6 million.
- Its Shares Outstanding has fluctuated over the past 5 years, first soared by 176.97% in 2023, then surged by 2250.13% in 2024.
- Quarter analysis of 5 years shows Cytokinetics' Shares Outstanding stood at $71.0 million in 2020, then grew by 19.41% to $84.8 million in 2021, then rose by 11.83% to $94.8 million in 2022, then grew by 7.17% to $101.6 million in 2023, then rose by 15.99% to $117.9 million in 2024.
- Its last three reported values are $117.9 million in Q3 2024, $117.5 million for Q2 2024, and $104.8 million during Q1 2024.